Contact Us

Researchers at the University of Rochester Medical Center are testing a new oral vaccine to prevent infection with HIV, the virus that causes AIDS. The vaccine is unique because it is given as a pill, unlike most HIV vaccines tested to date that have been given as shots.

Effectively responding to the high prevalence of HIV among men who have sex with men (MSM) in South Africa requires more research.

This was the call of numerous speakers at the second day of the Top2Btm symposium where researchers, medical professionals and policy makers met to discuss treatment, prevention and care of HIV for MSM. The symposium is based in Cape Town and hosted by the Anova Health Institute with support from PEPFAR.